References
Allen, J. A., Lowe, D. C., Roddie, I. C. and Wallace, W. F. M. 1973. Studies on sweating in clinical and experimental thyrotoxicosis. Clin. Sci. Mol., Med. 45, 765.
Aoki, V. S., Wilson, W. R. and Theilen, E. O. 1972. Studies on the reputed augmentation of the cardlovascular effects of the catecholamines in patients with spontaneous hyperthyroydism. J. Pharmac. Exp. Ther. 181, 362.
Aoki, V. S., Wilson, W. R., Thellen, E. O., Lukensmeyer, W. W. and Leverton, P. E. 1967. The effects of tri-iodothyronine on hemodynamic responses to epinephrine and norepinephrine in man. J. Pharmac. exp. Ther. 157, 62.
Brick, I., Hutchison, K. J., McDevitt, D. G., Roddie, I. C. and Shanks, R. G. 1968. comparison of the effects of I.C.I. 50, 172 and propranolol on the cardicvascular responses to adrenaline, isoprenaline and exercise. Br. J. Pharmac. 34, 127.
Buckle, R. M. 1968. Treatment of thyroid crisis by beta-adrenergic blockade. Acta endocrin. 57, 168.
Calroli, V. J. and Crcut, J. R. 1967. Role of the autonomic nervous system in the resting tachycardia of experimental hyperthyroldism. J. Pharmac. exp. Ther. 158, 55.
Carruthers, S. G., Ghosal, A., McDevitt, D. G., Nelson, J. K. and Shanks, R. G. 1974. The assessment of β-adrenoceptor blocking drugs in hyperthyroidism. Br. J. Clin. Pharmac. 1, 93.
Carruthers, S. G., Shanks, R. G. and McDevitt, D. G. 1976. Intrinsic heart rate on exercise and β-adrenoceptor blockade. Br. J. Clin. Pharmac. 3, 991.
Cleaveland, C. R., Rangno, R. E. and Shand, D. G. 1972. A standardised isoproterenol sensitivity test. Arch. int. Med. 130, 47.
Crile, G. 1929. Interdependence of thyrcid, adrenals and nervous system. Am. J. Surg. 6, 616.
Cullhed, I. and Parrow, A. 1968. Acute hemodynamic changes following bata-adrenergic blockade in hyperthyroidism. Acta med. Scand. 184, 235.
Das, G. and Krieger, M. 1969. Treatment of thyrotoxic storm with intravenous administration of propranolol. Arch. int. Med. 70, 985.
Dratman, M. B. 1974. On the mechanism of action of thyroxine, an amino acid alalog of tyrosine. J. Theor. Biol. 46, 255.
Dunlop, D. and Shanks, R. G. 1968. Selective blockade of adrenoceptive beta receptors in the heart. Br. J. Pharmac. 32, 201.
Galaburda, M., Rosman, N. P. and Haddow, J. E. 1974. Thyroid storm in an 11-year old boy managed by propranolol. Pediatrics 53, 920.
George, C. F., Conolly, M. E., Fenyvesi, T., Briant, R. and Dollery, C. T. 1972. Intravenously administered isoproterenol sulphate dose-response curves in man. Arch int. Med. 130, 361.
Georges, L. P., Santangelo, R. P., Macklin, J. F. and Canary, J. J. 1975. Metabolic effects of propranolol in thyrotoxicosis. I. Nitrogen, Calcium and Hydroxyproline. Metabolism 24, 11.
Goetsch, E. 1918. Adrenaline hypersentitiveness in clinical states of hyperthyroidism. N. Y. State J. Med. 18, 259.
Granville-Grossman, K. L. and Turner, P. 1966. The effect of propranolol on anxiety. Lancet i, 788.
Graves, R. J. 1832. On clinical instruction: with a comparative estimate of the mode in which it is conducted in the British and Continental Schools. London Med. Gaz. 10, 401.
Graves, R. J. 1835. London Med. Surg. J. 7, 516.
Graves, R. J. 1843. Clinical lectures on the practice of medicine. 1st Edition. London, New Sydenham Soc.
Grossman, W., Robin, N. I., Johnson, L. W., Brooks, H., Selenkon, H. A. and Dexter, L. 1971. Effects of beta blockade on the peripheral manifestations of thyrotoxicosis. Ann. int. Med. 74, 875.
Hadden, D. R., Bell, T. K., McDevitt, D. G., Shanks, R. G., Montgomery, D. A. D. and Weaver, J. A. 1989. Propranolol and the utilisation of radiolodine by the human thyroid gland. Acta endocrin. 61, 393.
Hadden, D. R. and McDevitt, D. G. 1974. Environmental stress and thyrotoxicosis: absence of association. Lancet ii, 577.
Hadden, D. R., Montgomery, D. A. D., Shanks, R. G. and Weaver, J. A. 1968. Propranolol and lodire-131 in the management of thyrotoxicosis. Lancet ii, 852.
Howe, H. and Shanks, R. G. 1986. Optical isomers of propranolol. Nature, Lond. 210, 1336.
Howitt, G. and Rowlands, D. J. 1966. Bata-sympathetic blockade in hyperthyroidism. Lancet ii, 628.
Howitt, G., Rowlands, D. J. fi Yeung, D. V. T. and Logan, W. F. W. G. 1968. Myocardial contractility and the effects of beta-adrenergic blockade in hypothyroidism and hyperthyroidism. Clin. Sci 34, 485.
Jaboulay, M. cited by Poncet, M. A. 1897. Le traitement chirurgical du goitre exophthalmique par la section on la resection duesympathique cervical. Bull. Acad. Med. 38, 121.
Jose, A. D. 1966. Effect of combined sympathetic and parasympathetic blockade on heart rate and cardiac function in man. Am. J. Cardicl. 18, 476.
Kelly, J. G. and McDevitt, D. G. 1977. Unpublished observations.
Lee, T. C., Coffey, R. J., Mackin, J., Cobb, M., Routon, J. and Canary, J. J. 1973. The use of propranolol in the surgical treatment of thyrotoxic patients. Ann. Surg. 177, 643.
Levey, G. S. 1971. Catecholamine sensitivity, thyrold hormone and the heart: A re-evaluation. Am. J. Med. 50, 413.
Levey, G. S. and Epstein, S. E. 1969. Myocardial adenyl cyclase: Activation by thyrold hormones and evidence for two adenyl cyclase systems. J. Clin. Invest. 48, 1663.
Levine, R. J., Oates, J. A., Vendsalu, A. and Sjoerdsma, A. 1962. Studies on the metabolism of aromatic amines in relation to altered thyroid function. J. Clin. Endocr. Metab. 22, 1242.
Lyons, H. A. 1973. Violence in Belfast: a review of the psychological effects. Community Health 5, 163.
McDevitt, D. G. 1977. Beta-adrenoceptor blockade in hyperthyroidism, in Advanced Medicine: Topics in Therapeutics III, edited by R. G. Shanks, Pitman Medical. London, pp. 100–115.
McDevitt, D. G., Riddell, J. G., Hadden, D. R. and Montgomery, D. A. D. 1977. Unpublished observations.
McDevitt, D. G. and Shanks, R. G. 1977. β-adrenergic receptor blocking drugs in hyperthyroidism, in Current Drug Reviews: Cardiology, Adis Press. In press.
McDevitt, D. G., Shanks, R. G., Hadden, D. R., Montgomery, D. A. D. and Weaver, J. A. 1968. The role of the thyroid gland in the control of heart rate. Lancet i, 998.
McLean, A. G. 1967. Adrenergic beta-blockade in thyrotoxic crisis. Med. J. Austral. 1, 229.
Margolius, H. S. and Gaffney, T. E. 1965. Effects of injected norepineephrine and sympathetic nerve stimulation in hypothyroid and hyperthyroid dogs. J. Pharmac. exp. Ther. 149, 329.
Marsden, C. D., Gimiette, T. M. D., McAllister, R. G., Owen, D. A. L. and Miller, T. N. 1968. Effect of ß-adrenergic blockade on finger tremor and Achilles reflex time in anxious and thyrotoxic patients. Acta endocrin. 57, 353.
Michel, R., Klepping, J., Tron-Loisel, H. and Truchot, R. 1963. Syntheses et activites biologiques de certains derives thyroxiniens et adrenergiques—I. Synthese des monoiodo-3-et di iodo 3: 5-synephrines et des di iodo-3: 5 et des triiodo-3: 5: 3-thyroadrenalines. Biochem. Pharmacol. 12, 717.
Michel, R., Klepping, J., Tron-Loisel, H. and Truchot, R. 1963. Syntheses et activities blologiques de certains derives thyroxiniens et adrenergiques—II. Etude experimentale des actions au riveau du coeur, des vaisseaux et de la musculature lisse de l’intestin des monoiodo-3-et dilodo-3: 5-synephrines et des dliodo-3: 5-et triiodo-3: 5-3′-thyroadrenalines. Biochem. Pharmacol. 12, 729.
Michel, R., Klepping, J., Truchot, R. and Tron-Loisel, H. 1963. Syntheses et activities biologiques de certains derives thyroxiniens et adrenergiques—III. Etude experimentale de certains effects endocriniens et generaux des monoiodo-3 et dilodo-3:5 synephrines et des diiodo-3: 5-et triiodo-3:5:3′-thyroadrenalines. Biochem. Pharmacol. 12, 741.
Michie, W., Hamer-Hodges, D. W., Pegg, C. A. S., Orr, F. G. G. and Bewsher, P. D. 1974. Betablockade and partial thyroidectomy for thyrotoxicosis. Lancet i, 1010.
Murchison, L. E., Bewsher, P. D., Chesters, M. I. and Ferrier, W. R. 1976. Comparison of propranolol and practolol in the management of hyperthyroidism. Br. J. Clin. Pharmac. 3, 273.
Nelson, J. C. and McDevitt, D. G. 1975. Comparative trial of propranolol and practolol in hyperthyroidism. Br. J. Clin. Prarmac. 2, 411.
Parry, C. H. 1825. Collections from the Unpublished Medical Writings, Vol. II, Underwoods, London, pp. 111.
Parsons, V. and Jewitt, D. 1967. Beta-adrenergic blockade in the management of acute thyrotoxic crisis, tachycardia and arrhythmias. Postgrad. Med. J. 43, 756.
Ramsay, I., Greer, S. and Bagley, C. 1973. Propranolol in neurotic and thyrotoxic anxiety. Br. J. Psychiat. 122, 555.
Schelling, J. L., Scazziga, B., Dufour, R. J., Milinkovic, N. and Weber, A. A. 1973. Effect of pindolol, a beta receptor antagonist, in hyperthyroidism. Clin. Pharmacol. Ther. 14, 158.
Schneckloth, R. E., Kurland, G. S. and Freedberg, A. S. 1953. Effect of variation in thyroid function on the pressor response to norepinephrine in man. Metabolism 2, 546.
Shanks, R. G., Hadder, D. R., Lowe, D. C., McDevitt, D. G. and Montgomery, D. A. D. 1969. Controlled trial of propranolol in thyrotoxiccsis. Lancet i, 993.
Sneddon, J. M. and Turner, P. 1966. Adrenergic blockade and the eye sigins of thyrotoxicosis. Lancet ii, 525.
Stroffer, S. S., Jiang, N-S., Gorman, C. A. and Pilker, M. 1973. Plasma catecholamines in hypothyroidism and hyperthyroidism. J. Clin. Endocrin. Metab. 36, 587.
Toft, A. D., Irvine, W. J. and Campbell, R. W. F. 1976. Assessment by continuous cardiac monitoring of minimum duration of pre-operative propranolol treatment in thyrotoxic patients. Clin. Endocrin. 5, 195.
Turner, P. 1974. β-adrenergic receptor blocking drugs in hyperthyroidism. Drugs. 7, 48.
Turner, P., Granville-Grossman, L. L. and Smart, J. V. 1965. Effect of adrenergic receptor blockade on the tachycardia of thyrotoxicosis and anxiety state. Lancet ii, 1316.
Van der Shoot, J. B. and Moran, N. C. 1965. An experimental evaluation of the reported influence of thyroxine on the cardiovascular effects of catecholamines. J. Pharmac. exp. Ther. 149, 336.
Wade, O. L. 1968. The computer and drug prescribing, in Computers in the service of medicine, edited by G. McLachlan and R. A. Shegog, London, p. 153.
Wiener, L., Stout, B. D. and Cox, J. W. 1969. Influence of beta sympathetic blockade (propranolol) on the hemodynamics of hyperthyroidism. Am. J. Med. 46, 227.
Wilson, W. R., Theilin, E. O., Hege, J. H. and Valenca, M. R. 1966. Effects of beta adrenergic receptor blockade in normal subjects before, during and after triiodo-thyronine induced hypermetabolism. J. Clin. Invest. 45, 1159.
Wurtman, R. J., Kopin, I. J. and Axelrod, J. 1963. Thyroid function and disposition of catecholamines. Endocrinology 73, 63.
Author information
Authors and Affiliations
Additional information
The Graves’ Lecture, 1977.
Rights and permissions
About this article
Cite this article
McDevitt, D.G. The clinical importance of the sympathetic nervous system in Graves’ disease. Ir J Med Sci 146, 353–364 (1977). https://doi.org/10.1007/BF03030990
Issue Date:
DOI: https://doi.org/10.1007/BF03030990